Tamm I - Search Results

1

Allogeneic SCT in refractory or relapsed adult ALL is effective without prior reinduction chemotherapy.

Terwey TH, Massenkeil G, Tamm I, Hemmati PG, Neuburger S, Martus P, Dörken B, Hoelzer D, Arnold R. Terwey TH, et al. Among authors: tamm i. Bone Marrow Transplant. 2008 Dec;42(12):791-8. doi: 10.1038/bmt.2008.258. Epub 2008 Aug 18. Bone Marrow Transplant. 2008. PMID: 18711350

2

Survival after reduced-intensity conditioning is not inferior to standard high-dose conditioning before allogeneic haematopoietic cell transplantation in acute leukaemias.

Massenkeil G, Nagy M, Neuburger S, Tamm I, Lutz C, le Coutre P, Rosen O, Wernecke KD, Dörken B, Arnold R. Massenkeil G, et al. Among authors: tamm i. Bone Marrow Transplant. 2005 Oct;36(8):683-9. doi: 10.1038/sj.bmt.1705123. Bone Marrow Transplant. 2005. PMID: 16113673

3

A pilot study of prophylactic donor lymphocyte infusions to prevent relapse in adult acute lymphoblastic leukemias after allogeneic hematopoietic stem cell transplantation.

Lutz C, Massenkeil G, Nagy M, Neuburger S, Tamm I, Rosen O, Dörken B, Arnold R. Lutz C, et al. Among authors: tamm i. Bone Marrow Transplant. 2008 May;41(9):805-12. doi: 10.1038/sj.bmt.1705981. Epub 2008 Jan 14. Bone Marrow Transplant. 2008. PMID: 18195682

4

Successful salvage treatment of disseminated cutaneous fusariosis with liposomal amphotericin B and terbinafine after allogeneic stem cell transplantation.

Neuburger S, Massenkeil G, Seibold M, Lutz C, Tamm I, le Coutre P, Graf B, Doerken B, Arnold R. Neuburger S, et al. Among authors: tamm i. Transpl Infect Dis. 2008 Jul;10(4):290-3. doi: 10.1111/j.1399-3062.2007.00296.x. Epub 2008 Jan 14. Transpl Infect Dis. 2008. PMID: 18194367

5

5-Aza-2'-deoxycytidine induces p21WAF expression by demethylation of p73 leading to p53-independent apoptosis in myeloid leukemia.

Schmelz K, Wagner M, Dörken B, Tamm I. Schmelz K, et al. Among authors: tamm i. Int J Cancer. 2005 May 1;114(5):683-95. doi: 10.1002/ijc.20797. Int J Cancer. 2005. PMID: 15609309

6

In vivo expression of survivin and its splice variant survivin-2B: impact on clinical outcome in acute myeloid leukemia.

Wagner M, Schmelz K, Wuchter C, Ludwig WD, Dörken B, Tamm I. Wagner M, et al. Among authors: tamm i. Int J Cancer. 2006 Sep 15;119(6):1291-7. doi: 10.1002/ijc.21995. Int J Cancer. 2006. PMID: 16619249

7

Epigenetic and genetic analysis of the survivin promoter in acute myeloid leukemia.

Wagner M, Schmelz K, Dörken B, Tamm I. Wagner M, et al. Among authors: tamm i. Leuk Res. 2008 Jul;32(7):1054-60. doi: 10.1016/j.leukres.2007.11.013. Epub 2008 Feb 21. Leuk Res. 2008. PMID: 18206228

8

Antisense therapy in oncology: new hope for an old idea?

Tamm I, Dörken B, Hartmann G. Tamm I, et al. Lancet. 2001 Aug 11;358(9280):489-97. doi: 10.1016/S0140-6736(01)05629-X. Lancet. 2001. PMID: 11513935 Review.

9

Induction of gene expression by 5-Aza-2'-deoxycytidine in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) but not epithelial cells by DNA-methylation-dependent and -independent mechanisms.

Schmelz K, Sattler N, Wagner M, Lübbert M, Dörken B, Tamm I. Schmelz K, et al. Among authors: tamm i. Leukemia. 2005 Jan;19(1):103-11. doi: 10.1038/sj.leu.2403552. Leukemia. 2005. PMID: 15510208

10

Transcriptional regulation of human survivin by early growth response (Egr)-1 transcription factor.

Wagner M, Schmelz K, Dörken B, Tamm I. Wagner M, et al. Among authors: tamm i. Int J Cancer. 2008 Mar 15;122(6):1278-87. doi: 10.1002/ijc.23183. Int J Cancer. 2008. PMID: 18027854

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

257 results

Search Page

Filters